| Literature DB >> 28484601 |
Yihong Chen1,2, Haitao Bi3,2, Xiaoyun Li4, Zezhi Zhang3,2, Haitao Yue3,2, Shaoping Weng3,2, Jianguo He1,3,2.
Abstract
A previous study found the key transcription factor of Litopenaeus vannamei PERK-eIF2α pathway cyclic AMP-dependent transcription factor 4 (LvATF4) was involved in the transcriptional regulation of white spot syndrome virus (WSSV) gene wsv023. Knocked-down expression of LvATF4 reduced the viral copy number and the cumulative mortality of WSSV-infected shrimp. These results suggested that wsv023 may be critical to WSSV infection but the precise function of wsv023 was still unknown. By using co-immunoprecipitation and pull-down assays, we show that wsv023 interacts with L. vannamei gamma complex-associated protein 2 (LvGCP2), which is the core protein of the γ-tubulin small complex. Knocked-down, the wsv023 gene significantly reduced the copy number of WSSV in L. vannamei muscle, as well as the cumulative mortality of infected shrimp. And PERK-eIF2α pathway inhibition also showed reduced virus copy number and abrogated shrimp mortality. Furthermore, overexpression of wsv023 inhibited the formation of microtubules in 293T cells. Flow cytometry revealed that WSSV infection similarly decreased the formation of microtubules in L. vannamei haemocytes. These findings suggested that wsv023 plays a role in microtubule organization in host cells, which in turn may be beneficial to WSSV.Entities:
Keywords: Litopenaeus vannamei; unfolded protein response; white spot syndrome virus; wsv023
Year: 2017 PMID: 28484601 PMCID: PMC5414238 DOI: 10.1098/rsos.160379
Source DB: PubMed Journal: R Soc Open Sci ISSN: 2054-5703 Impact factor: 2.963
Summary of primers used in this study.
| primers | sequence (5′–3′) |
|---|---|
| LvGCP2-5race1 | CGTGTGATAAGGCCGGTTATCCAGCCAA |
| LvGCP2-5race2 | TTTCTCCTCTTTCAACTGCTCGCATGGC |
| LvGCP2-3race1 | ACCTGCTGAGCCTCATGATGGGGATAGA |
| LvGCP2-3race2 | ATGACGCCCCAGAGTTTACTGTCGATCC |
| LvGCP3-5race1 | ATCTGAAGCAATGAAGAACTCGTGGTGA |
| LvGCP3-5race2 | GAGCATAACATACAGAGGTGTGCAGGCC |
| LvGCP3-3race1 | ACCTGTACCCACATAATCTGTCTTCCCT |
| LvGCP3-3race2 | CTCAGTATGAGGAACCAGACATCCTCGA |
| pACB-LvGCP2-KpnI-Flag-F | ATA |
| pACB-LvGCP2-Xba I-R | ATATCTAGACTTCACCCTGAAACCGGGCCGCTG |
| pACB/IZ-wsv023-EcoR I-F | ATA |
| pACB/IZ-wsv023-CG-Xho I-R | TTA |
| pCDNA3-Flag-wsv023-F1 | ATGGATTACAAGGATGACGACGATAAGATGAGCTCGGGTAGTATCAACA |
| pCDNA3-Flag-wsv023-BamH I-F2 | TAT |
| pCDNA3-Flag-wsv023-Xho I-R | TTA |
| pCDNA3-Flag-wsv220(N250)-F1 | ATGGATTACAAGGATGACGACGATAAGATGGCAGGGAATAGAACCC |
| pCDNA3-Flag-wsv220(N250)-BamH I-F2 | TAT |
| pCDNA3-Flag- wsv220(N250)-Xho I-R | TTA |
| pACB-LvGST-Kpn I-F | ATA |
| pACB-LvGST-Apa I-R | TAT |
| pACB/IZ-eGFP-Kpn I-Flag-F1 | ATA |
| pACB/IZ-eGFP-EcoR I-Flag-R | TAT |
| pET32A-wsv023-Kpn I-F | TTA |
| pET32A-wsv023-BamH I-R | ATT |
| pET32A-eGFP-Kpn I-F | TTA |
| pET32A-eGFP-BamH I-R | ATT |
| pMAL-C2X-LvGCP2-BamH I-450-F | AAT |
| pMAL-C2X-LvGCP2-Sal I-450-R | ATA |
| DsRNA-wsv023-469-T7-F1 | GGATCCTAATACGACTCACTATAGGTTTGGAGAATCTGCATCAGAGA |
| DsRNA-wsv023-469-R1 | GAATTGCAGTGATAGGCACAG |
| DsRNA-wsv023-469-F2 | TTTGGAGAATCTGCATCAGAGA |
| DsRNA-wsv023-469-T7-R2 | GGATCCTAATACGACTCACTATAGGGAATTGCAGTGATAGGCACAG |
| DsRNA-eGFP504-T7-F1 | GGATCCTAATACGACTCACTATAGGCGACGTAAACGGCCACAAGTT |
| DsRNA-eGFP504-R1 | ATGGGGGTGTTCTGCTGGTAG |
| DsRNA-eGFP504-F2 | CGACGTAAACGGCCACAAGTT |
| DsRNA-eGFP504-T7-R2 | GGATCCTAATACGACTCACTATAGGATGGGGGTGTTCTGCTGGTAG |
| SQPCR-wsv023-536-F | GAAGTTGACTCCATTATTCGCCA |
| SQPCR-wsv023-536-R | AAGTTCCTCAACAGGGGAATTATAG |
| SQ-PCR-LvEF1α-329-F | CCAGGGTGAAGCACAGCAAC |
| SQ-PCR-LvEF1α-329-R | CGACAAGCGAACCATCGAGA |
| QPCR-Lvα-Tubulin-F | CGTCGAGCCCTACAACTCCAT |
| QPCR-Lvα-Tubulin-R | GCCTCGTTGTCGACCATGA |
| QPCR-Lvβ-Tubulin-F | TCCAAGATCCGGGAGGAGTA |
| QPCR-Lvβ-Tubulin-R | CGGTATGACGGAGAACGTGTT |
| QPCR-Lvγ-Tubulin-F | ACGTAATGCGTCGCTTGCT |
| QPCR-Lvγ-Tubulin-R | CGATCCAAGGGAGTAGAGACCAT |
| QPCR-wsv069-F | TGTTTTCTGTATGTAATGCGTGTAGGT |
| QPCR-wsv069-R | CCCACTCCATGGCCTTCA |
| QPCR-LvEF-1α-F | AAGGCCCTCAAGAAGAAGTAAAT |
| QPCR-LvEF-1α-R | TTGACAACCATACCTGGCTTC |
aNucleotides in bold indicate restriction sites introduced for cloning.
Figure 1.Interactions between w023 and LvGCP2. (a) Co-IP assay revealed interactions between LvGCP2 (FLAG) and wsv023 (V5); (b) pull-down assay confirmed interactions between w023 and LvGCP2. The blots were resolved by SDS-PAGE and visualized by immunoblotting with anti-V5 or anti-Flag antibody.
Figure 2.Cumulative mortality or WSSV copy number decreased in shrimps treatment with dswsv023 plus WSSV infection. RT-PCR analysis gene expression of wsv023 (a(i)), all samples were taken 72 h after injection with indicated dsRNA. The internal control was LvEF1α. (a(ii)) Shrimp (n = 50) were injected intramuscularly with PBS, dswsv023 or dseGFP. At 48 h after the initial injection, shrimps were infected with WSSV or PBS again (negative control), and cumulative mortality of shrimps was recorded every 12 h. (b) The bars indicate mean values ± s.d. of the log10 WSSV copy number per 1 g muscle (n = 3). The statistical significance was calculated using Student's t-test (** indicates p < 0.01 compared with control).
Figure 3.PERK-eIF2α pathway inhibition restrained WSSV infection. Shrimp were injected with Salubrinal or DMSO (negative control). (a) Western blot assay showed that Salubrinal injection reduced the phosphorylation of eIF2α compared with the control; (b) cumulative mortality was recorded every 12 h post-challenge. Data were derived from three independent experiments and shown as mean ± s.d. Differences in mortality levels between treatments were analysed by Kaplan–Meier plot (log-rank Х2 test). Significant differences in L. vannamei mortality were marked with asterisks (** indicates p < 0.01); (c) DNA were collected from shrimp and detected WSSV copy numbers in each samples by quantity RT-PCR. Data were expressed as mean fold change (mean ± s.d., n = 3) from the untreated group, significant differences in L. vannamei mortality were marked with asterisks (** indicates p < 0.01).
Figure 4.Overexpressed wsv023 in 293T cells decreased the microtubules formation. (a) Cells overexpressed wsv023 with fluorescence value significant lower that overexpressed wsv220N250, with tubulin tracker treatment. (b) Cells overexpressed wsv023 did not decrease the expression of α/β-tubulins. Data were expressed as mean fold change (mean ± s.d., n = 3) from the untreated group. The bars with different letters indicate statistical differences (p < 0.05). Statistical significance was determined by one-way ANOVA.
Figure 5.Expression profile of Lvα-tubulin, Lvβ-tubulin and Lvγ-tubulin, and microtubules formation condition in haemocytes of WSSV-challenged L. vannamei. The mRNAs were collected at 0, 3, 6, 9, 12, 18, 24, 30, 36, 48, 72 and 96 hpi. The expression level of Lvα-tubulin, Lvβ-tubulin and Lvγ-tubulin was measured by real-time RT-PCR. The relative expression of Lvα-tubulin (a(i)), Lvβ-tubulin (a(ii)) and Lvγ-tubulin (a(iii)) after injection with the WSSV in haemocytes were normalized to LvEF-1a and compared against time zero. The results were based on three independent experiments and expressed as the mean values ± s.d. Statistical significance was determined by Student's t-test (*indicates p < 0.05, **indicates p < 0.01 compared with controls at each time point). (b) Haemocytes collected from WSSV-infected shrimp with fluorescence value significant lower than the control group.
Figure 6.Illustration of wsv023 influence on the microtubule formation in WSSV-infected cells. WSSV infection activated the PERK-eIF2α pathway, which enhanced the expression of LvATF4. Then LvATF4 increased the expression of wsv023 and WSSV copies. Moreover, wsv023 interacted with LvGCP2, which should interact with LvGCP3 under natural conditions, and inhibit microtubule formation of L. vannamei cells.